期刊文献+

用于组织工程医疗产品海藻酸钠主要性能指标的测定 被引量:1

Sodium alginate serves as an important indicator for tissue-engineered medical products
下载PDF
导出
摘要 背景:海藻酸钠的平均分子质量及其分子质量分布,以及化学组成和序列结构的不同将会导致海藻酸钠最终用途的不同。目的:测定用于组织工程医疗产品海藻酸钠的平均分子质量及分子质量分布,以及化学组成和序列结构。方法:采用高效液相凝胶渗透色谱联合多角度激光散射测定仪法测定海藻酸钠的平均分子质量及分子质量分布,并通过高分辨1H-核磁共振光谱法测定其化学组成和序列结构。结果与结论:组织工程医疗产品海藻酸钠样品的数均分子质量为7.360×104,重均分子质量为1.031×105,分子质量分布为1.401,G单体含量为0.405,M单体含量为0.595,M/G为1.47,连续M单体的平均数量为2.78,连续G单体的平均数量为1.89,连续G单体数量大于1的数值为2.72。 BACKGROUND:Different average molecular weight and molecular weight distribution,as well as different chemical composition and sequence structure of sodium alginate will results in different applications of sodium alginate.OBJECTIVE:To measure the average molecular weight and molecular weight distribution,as well as different chemical composition and sequence structure of sodium alginate used for tissue-engineered medical products.METHODS:The average molecular weight and the molecular weight distribution were detected by size exclusion chromatography-multi-angle laser light scattering.The chemical composition and sequence structure were detected by Hydrogen-1 nuclear magnetic resonance.RESULTS AND CONCLUSION:The sample's number-average molecular weight was 7.360×104,weight-average molecular weight was 1.031×105 and the molecular weight distribution (Mw/Mn) was 1.401.Fg was 0.405,Fm was 0.595,the M/G was 1.47,Nm was 2.78,Ng was 1.89 and Ng1 was 2.72.
出处 《中国组织工程研究》 CAS CSCD 2012年第38期7140-7144,共5页 Chinese Journal of Tissue Engineering Research
基金 十一五"863"干细胞与组织工程重大专项项目(2006AA02A118):干细胞与组织工程技术标准研究~~
  • 相关文献

参考文献17

二级参考文献163

共引文献113

同被引文献21

  • 1龚泰芳,方彩云,陈文,王平年.海藻酸盐的理化特性及其在组织工程研究和临床中的应用[J].中国组织工程研究与临床康复,2007,11(18):3613-3616. 被引量:13
  • 2顾其胜,朱彬.海藻酸盐基生物医用材料[J].中国组织工程研究与临床康复,2007,11(26):5194-5198. 被引量:30
  • 3顾其胜,奚廷斐.海藻酸与临床医学.上海:第二军医大学出版社,2006:1-200. 被引量:1
  • 4Andersen T, Strand BL, Formo K, et al. Alginates as biomaterials in tis- sue engineering. Carbohydr Chem, 2012, 37: 227-258. 被引量:1
  • 5Lee RJ, Hinson A, Helgerson S, et al. Polymer-based restoration of left ventricular mechanics. Cell Transplant, 2013, 22(3): 529-533. 被引量:1
  • 6European Directorate for the Quality of Medicines & HealthCare. Eu-ropean Pharmacopoeia. 7th ed. Strasbourg: EDQM, 2010:2909-2910. 被引量:1
  • 7British Pharmacopoeia Commission. British Pharmacopoeia 2012. London: TSO, 2012: 1951. 被引量:1
  • 8The United States Pharmacopeial Convention. United States Pharma- copeia 35/National Formulary 30. Maryland: United States Pharmaco- peial Convention, 2012: 1950. 被引量:1
  • 9国家药典委员会.国家药品标准工作手册.3版.1998:110.142. 被引量:1
  • 10American Society for Testing and Materials. ASTM F2064-00(2006)el Standard Guide for Characterization and Testing of Alginates as Start- ing Materials Intended for Use in Biomedical and Tissue-Engineered Medical Products Application. Pennsylvania: ASTM International, 2006: 1-8. 被引量:1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部